TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›REFI
REFI logo

REFI

Chicago Atlantic Real Estate Finance, Inc.

Next earnings Aug 5, 2026 · consensus $0.44 EPS, $15.7M rev

Last earnings -5.1% on 2026-05-07

Hold
$10.68
▼ -3.52%
$10.68▼ -14.51%
over 1Y
L $10.57H $12.85
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-3.5%
1W-3.2%
1M-5.3%
3M-3.0%
YTD-9.2%
1Y-14.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Undervalued
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 11 analysts
Buy

Cheap cannabis-lending mortgage REIT below book with a fat yield, but slipping earnings and a dividend outrunning cash flow cap the upside.

P/E (price / FY diluted EPS) 6.4 · FY2025

The read

Middling fundamentals offset by an attractive price (~40% below fair value) — worth a look on the value angle.

REFI is a Maryland commercial mortgage REIT that lends against cannabis cultivation/processing facilities — a niche that is the whole story. The balance sheet is genuinely strong: liabilities/equity of just 0.38x, long-term debt of only $49.3M against $308M of equity, and a 73.7% net margin with 11.7% ROE. At $10.68 the stock trades at 6.4x FY2025 diluted EPS and roughly 0.73x book ($308M equity vs. $225M market cap), having already slid from the $12.27 close the 10-K cites on March 6, 2026. On valuation alone this looks like a discounted, profitable lender.

The caution is that the fundamentals are quietly eroding, not compounding. Net income has stepped down three years running — $38.7M (FY2023) → $37.0M (FY2024) → $36.0M (FY2025) — and diluted EPS fell 10.6% to $1.68. More telling, the payout looks stretched: dividends paid of $43.8M exceed both FY2025 net income ($36.0M) and operating cash flow ($28.8M), retained earnings sank to -$15.5M (worse by 53%), and cash dropped 43.4% to $14.9M. REITs must distribute ~90% of taxable income and distributions can run ahead of GAAP earnings, but a dividend funded beyond earnings and operating cash — while the cash balance shrinks — is not indefinitely sustainable without loan-principal recycling or new capital.

Is REFI a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~10.68
  • Short call 11 @ ~0.35 est
debit $1,033max +$67max −$1,032BE 10.33

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25
Revenue$48.9M———
Gross profit————
Operating income————
Net income$32.3M$38.7M$37.0M$36.0M
Diluted EPS$1.82$2.11$1.88$1.68
Net margin66.1%———

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield15.8%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt$334M
Net cash-$319M
Piotroski F-Score2/6

Capital returns

Buyback yield—
Dividend yield (est.)19.3%
Shareholder yield19.3%
Shares Δ YoY+0.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Material agreement2026-06-18

    Entered material definitive agreement (item 1.01), likely a new/amended financing or loan

  2. 8-K Shareholder vote2026-06-11

    Annual meeting voting results reported (item 5.07)

  3. 8-K Earnings results2026-05-07

    Q1 2026 report; equity ~$308M, low leverage 0.38x, OCF trending up

  4. 10-Q Quarterly report2026-05-07

    Q1 2026 report; equity ~$308M, low leverage 0.38x, OCF trending up

  5. DEF 14A Proxy statement2026-04-23

    2026 proxy: board election and routine governance/comp matters

  6. 8-K Earnings results2026-03-12

    FY2025 10-K: net income $36.0M, EPS $1.68 (-10.6%), dividends +5.3%

  7. 10-K Annual report2026-03-12

    FY2025 10-K: net income $36.0M, EPS $1.68 (-10.6%), dividends +5.3%

  8. S-3 Shelf registration (potential raise)2026-01-16

    Shelf registration filed, enabling future equity/debt issuance (potential dilution)

  9. 8-K Earnings results2025-11-04

    Q3 2025 report; stable equity, cannabis-lending portfolio performing

Recent filings

all on EDGAR ↗
425Filing2026-06-18open ↗425Filing2026-06-18open ↗DEFA14AFiling2026-06-18open ↗425Filing2026-06-18open ↗8-KPeriod ending 2026-06-172026-06-18open ↗8-KPeriod ending 2026-06-112026-06-11open ↗8-KPeriod ending 2026-05-072026-05-07open ↗10-QPeriod ending 2026-03-312026-05-07open ↗ARSPeriod ending 2025-12-312026-04-23open ↗DEF 14APeriod ending 2026-04-222026-04-23open ↗4Period ending 2026-04-202026-04-22open ↗4Period ending 2026-04-202026-04-22open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueB+
GrowthF
ProfitabilityA-
Financial healthA-
MomentumF
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$14.99

Undervalued +40% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.68 × (8.5 + 1.5 × 0.0% growth) × 1.05 quality = 8.9× multiple. An estimate, not a price target.

10.4352-week12.30
Revenue
$48.9M
Net margin
73.7%
ROE
11.7%
P/E
6.4

SEC fundamentals · FY 2025

'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$48.9M
Net income$36.0M-2.8%
Diluted EPS$1.68-10.6%
Cash & equivalents$14.9M-43.4%
Total assets$425M-2.4%
Total liabilities$117M-7.2%
Stockholders' equity$308M-0.4%
L/E: 0.38x

Frequently asked

Is Chicago Atlantic Real Estate Finance, Inc. (REFI) a buy?
REFI currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Cheap cannabis-lending mortgage REIT below book with a fat yield, but slipping earnings and a dividend outrunning cash flow cap the upside.
What is REFI's fair value?
A Modified-Graham model based on REFI's SEC fundamentals estimates a fair value of about $14.99. It is an estimate from reported earnings, not a price target.
Is REFI overvalued or undervalued?
Against a Modified-Graham fair-value estimate, REFI currently appears undervalued relative to its SEC-grounded earnings power.
What is Chicago Atlantic Real Estate Finance, Inc.'s quality score?
REFI scores 61.88199247664118/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001867949, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 7/3/2026, 11:06:47 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 7:06 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-04-20
Konigsberg Brandon
Director
Award6.32K
2026-04-20
Kite David
President and COO
Award37.1K
2026-04-20
Silverman Phillip
Chief Financial Officer
Award32.5K
2026-04-20
Stavola Elizabeth Mary
Director
Award6.32K
2026-04-20
Mazarakis John
Executive Chairman
Award37.1K
2026-04-20
Cappell Anthony
Co-Chief Executive Officer
Award37.1K
2026-04-20
Papastavrou Jason D
Director
Award6.32K
2026-04-20
Sack Peter
Co-Chief Executive Officer
Award37.1K

Earnings history

beat/miss · move
2026-05-07Miss -47.3% est▼ -5.85%8-K ↗
2026-03-12Miss -6.9% est▲ +2.07%8-K ↗
2025-11-04Miss -6.4% est▲ 0.00%8-K ↗
2025-08-07Miss -9.2% est▲ +1.53%8-K ↗
2025-05-07—▲ +0.47%8-K ↗
2025-03-12—▲ +0.52%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score62 vs 67
Revenue growth— vs 7.5%
Net margin73.7% vs 10.0%
Return on equity11.7% vs 12.0%
P/E6.4 vs 26.2